Clinical and Experimental Pediatrics

The Korean Pediatric Society (대한소아청소년과학회)
권호 표지
DOI QR코드

DOI QR Code

Kabuki syndrome: clinical and molecular characteristics

  • Cheon, Chong-Kun (Department of Pediatrics, Pusan National University Children's Hospital, Pusan National University School of Medicine) ;
  • Ko, Jung Min (Department of Pediatrics, Seoul National University College of Medicine)
  • Received : 2015.03.25
  • Accepted : 2015.06.22
  • Published : 2015.09.10
Download PDF
⟨ Previous Next ⟩

Abstract

Kabuki syndrome (KS) is a rare syndrome characterized by multiple congenital anomalies and mental retardation. Other characteristics include a peculiar facial gestalt, short stature, skeletal and visceral abnormalities, cardiac anomalies, and immunological defects. Whole exome sequencing has uncovered the genetic basis of KS. Prior to 2013, there was no molecular genetic information about KS in Korean patients. More recently, direct Sanger sequencing and exome sequencing revealed KMT2D variants in 11 Korean patients and a KDM6A variant in one Korean patient. The high detection rate of KMT2D and KDM6A mutations (92.3%) is expected owing to the strict criteria used to establish a clinical diagnosis. Increased awareness and understanding of KS among clinicians is important for diagnosis and management of KS and for primary care of KS patients. Because mutation detection rates rely on the accuracy of the clinical diagnosis and the inclusion or exclusion of atypical cases, recognition of KS will facilitate the identification of novel mutations. A brief review of KS is provided, highlighting the clinical and genetic characteristics of patients with KS.

Keywords

References

  1. Matsumoto N, Niikawa N. Kabuki make-up syndrome: a review. Am J Med Genet C Semin Med Genet 2003;117C:57-65. https://doi.org/10.1002/ajmg.c.10020
  2. Ng SB, Bigham AW, Buckingham KJ, Hannibal MC, McMillin MJ, Gildersleeve HI, et al. Exome sequencing identifies MLL2 mutations as a cause of Kabuki syndrome. Nat Genet 2010;42:790-3. https://doi.org/10.1038/ng.646
  3. Niikawa N, Matsuura N, Fukushima Y, Ohsawa T, Kajii T. Kabuki make-up syndrome: a syndrome of mental retardation, unusual facies, large and protruding ears, and postnatal growth deficiency. J Pediatr 1981;99:565-9. https://doi.org/10.1016/S0022-3476(81)80255-7
  4. Adam MP, Hudgins L. Kabuki syndrome: a review. Clin Genet 2005;67:209-19.
  5. Niikawa N, Kuroki Y, Kajii T, Matsuura N, Ishikiriyama S, Tonoki H, et al. Kabuki make-up (Niikawa-Kuroki) syndrome: a study of 62 patients. Am J Med Genet 1988;31:565-89. https://doi.org/10.1002/ajmg.1320310312
  6. Li Y, Bogershausen N, Alanay Y, Simsek Kiper PO, Plume N, Keupp K, et al. A mutation screen in patients with Kabuki syndrome. Hum Genet 2011;130:715-24. https://doi.org/10.1007/s00439-011-1004-y
  7. Cheon CK, Sohn YB, Ko JM, Lee YJ, Song JS, Moon JW, et al. Identification of KMT2D and KDM6A mutations by exome sequencing in Korean patients with Kabuki syndrome. J Hum Genet 2014;59:321-5. https://doi.org/10.1038/jhg.2014.25
  8. Hannibal MC, Buckingham KJ, Ng SB, Ming JE, Beck AE, McMillin MJ, et al. Spectrum of MLL2 (ALR) mutations in 110 cases of Kabuki syndrome. Am J Med Genet A 2011;155A:1511-6.
  9. Banka S, Veeramachaneni R, Reardon W, Howard E, Bunstone S, Ragge N, et al. How genetically heterogeneous is Kabuki syndrome?: MLL2 testing in 116 patients, review and analyses of mutation and phenotypic spectrum. Eur J Hum Genet 2012;20:381-8. https://doi.org/10.1038/ejhg.2011.220
  10. Bogershausen N, Wollnik B. Unmasking Kabuki syndrome. Clin Genet 2013;83:201-11. https://doi.org/10.1111/cge.12051
  11. Lederer D, Grisart B, Digilio MC, Benoit V, Crespin M, Ghariani SC, et al. Deletion of KDM6A, a histone demethylase interacting with MLL2, in three patients with Kabuki syndrome. Am J Hum Genet 2012;90:119-24. https://doi.org/10.1016/j.ajhg.2011.11.021
  12. Miyake N, Mizuno S, Okamoto N, Ohashi H, Shiina M, Ogata K, et al. KDM6A point mutations cause Kabuki syndrome. Hum Mutat 2013;34:108-10. https://doi.org/10.1002/humu.22229
  13. Banka S, Lederer D, Benoit V, Jenkins E, Howard E, Bunstone S, et al. Novel KDM6A (UTX) mutations and a clinical and molecular review of the X-linked Kabuki syndrome (KS2). Clin Genet 2015; 87:252-8. https://doi.org/10.1111/cge.12363
  14. Prasad R, Zhadanov AB, Sedkov Y, Bullrich F, Druck T, Rallapalli R, et al. Structure and expression pattern of human ALR, a novel gene with strong homology to ALL-1 involved in acute leukemia and to Drosophila trithorax. Oncogene 1997;15:549-60. https://doi.org/10.1038/sj.onc.1201211
  15. Dillon SC, Zhang X, Trievel RC, Cheng X. The SET-domain protein superfamily: protein lysine methyltransferases. Genome Biol 2005; 6:227. https://doi.org/10.1186/gb-2005-6-8-227
  16. Issaeva I, Zonis Y, Rozovskaia T, Orlovsky K, Croce CM, Nakamura T, et al. Knockdown of ALR (MLL2) reveals ALR target genes and leads to alterations in cell adhesion and growth. Mol Cell Biol 2007;27:1889-903. https://doi.org/10.1128/MCB.01506-06
  17. Agger K, Cloos PA, Christensen J, Pasini D, Rose S, Rappsilber J, et al. UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development. Nature 2007;449:731-4. https://doi.org/10.1038/nature06145
  18. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell 2007; 128:735-45. https://doi.org/10.1016/j.cell.2007.02.009
  19. Dubuc AM, Remke M, Korshunov A, Northcott PA, Zhan SH, Mendez-Lago M, et al. Aberrant patterns of H3K4 and H3K27 histone lysine methylation occur across subgroups in medulloblastoma. Acta Neuropathol 2013;125:373-84. https://doi.org/10.1007/s00401-012-1070-9
  20. White SM, Thompson EM, Kidd A, Savarirayan R, Turner A, Amor D, et al. Growth, behavior, and clinical findings in 27 patients with Kabuki (Niikawa-Kuroki) syndrome. Am J Med Genet A 2004; 127A:118-27. https://doi.org/10.1002/ajmg.a.20674
  21. Peterson-Falzone SJ, Golabi M, Lalwani AK. Otolaryngologic manifestations of Kabuki syndrome. Int J Pediatr Otorhinolaryngol 1997;38:227-36. https://doi.org/10.1016/S0165-5876(96)01443-7
  22. Tanaka R, Takenouchi T, Uchida K, Sato T, Fukushima H, Yoshihashi H, et al. Congenital corneal staphyloma as a complication of Kabuki syndrome. Am J Med Genet A 2012;158A:2000-2. https://doi.org/10.1002/ajmg.a.35453
  23. Abdel-Salam GM, Afifi HH, Eid MM, el-Badry TH, Kholoussi NM. Anorectal anomalies, diaphragmatic defect, cleft palate, lower lip pits, hypopigmentation and hypogammaglobulinemia A in Kabuki syndrome: a rare combination. Genet Couns 2008;19:309-17.
  24. Ho J, Fox D, Innes AM, McLeod R, Butzner D, Johnson N, et al. Kabuki syndrome and Crohn disease in a child with familial hypocalciuric hypercalcemia. J Pediatr Endocrinol Metab 2010;23:975-9.
  25. Gillis R, Klar A, Gross-Kieselstein E. The Niikawa-Kuroki (Kabuki make-up) syndrome in a Moslem Arab child. Clin Genet 1990;38: 378-81.
  26. Kuroki Y, Katsumata N, Eguchi T, Fukushima Y, Suwa S, Kajii T. Precocious puberty in Kabuki makeup syndrome. J Pediatr 1987; 110:750-2. https://doi.org/10.1016/S0022-3476(87)80018-5
  27. Ewart-Toland A, Enns GM, Cox VA, Mohan GC, Rosenthal P, Golabi M. Severe congenital anomalies requiring transplantation in children with Kabuki syndrome. Am J Med Genet 1998;80:362-7. https://doi.org/10.1002/(SICI)1096-8628(19981204)80:4<362::AID-AJMG11>3.0.CO;2-W
  28. Miyake N, Koshimizu E, Okamoto N, Mizuno S, Ogata T, Nagai T, et al. MLL2 and KDM6A mutations in patients with Kabuki syndrome. Am J Med Genet A 2013;161A:2234-43.
  29. Casanova M, Selicorni A, Ferrari A. Cancer predisposition in children with Kabuki syndrome. Am J Med Genet A 2011;155A: 1504.
  30. Hoffman JD, Ciprero KL, Sullivan KE, Kaplan PB, McDonald-McGinn DM, Zackai EH, et al. Immune abnormalities are a frequent manifestation of Kabuki syndrome. Am J Med Genet A 2005;135:278-81.
  31. Chrzanowska KH, Krajewska-Walasek M, Kus J, Michalkiewicz J, Maziarka D, Wolski JK, et al. Kabuki (Niikawa-Kuroki) syndrome associated with immunodeficiency. Clin Genet 1998;53:308-12.
  32. Scherer S, Theile U, Beyer V, Ferrari R, Kreck C, Rister M. Patient with Kabuki syndrome and acute leukemia. Am J Med Genet A 2003;122A:76-9. https://doi.org/10.1002/ajmg.a.20261
  33. Ming JE, Russell KL, McDonald-McGinn DM, Zackai EH. Autoimmune disorders in Kabuki syndrome. Am J Med Genet A 2005; 132A:260-2. https://doi.org/10.1002/ajmg.a.30332
  34. Verrotti A, Agostinelli S, Cirillo C, D'Egidio C, Mohn A, Boncimino A, et al. Long-term outcome of epilepsy in Kabuki syndrome. Seizure 2011;20:650-4. https://doi.org/10.1016/j.seizure.2011.06.005
  35. Ho HH, Eaves LC. Kabuki make-up (Niikawa-Kuroki) syndrome: cognitive abilities and autistic features. Dev Med Child Neurol 1997;39:487-90.
  36. Wessels MW, Brooks AS, Hoogeboom J, Niermeijer MF, Willems PJ. Kabuki syndrome: a review study of three hundred patients. Clin Dysmorphol 2002;11:95-102. https://doi.org/10.1097/00019605-200204000-00004
  37. Bjornsson HT, Benjamin JS, Zhang L, Weissman J, Gerber EE, Chen YC, et al. Histone deacetylase inhibition rescues structural and functional brain deficits in a mouse model of Kabuki syndrome. Sci Transl Med 2014;6:256ra135. https://doi.org/10.1126/scitranslmed.3009278
  38. Kim SJ, Cho SY, Maeng SH, Sohn YB, Kim SJ, Ki CS, et al. A novel MLL2 gene mutation in a Korean patient with Kabuki syndrome. Korean J Pediatr 2013;56:355-8. https://doi.org/10.3345/kjp.2013.56.8.355

Cited by

  1. Array comparative genomic hybridization and genomic sequencing in the diagnostics of the causes of congenital anomalies vol.58, pp.2, 2015, https://doi.org/10.1007/s13353-016-0376-z
  2. The defining DNA methylation signature of Kabuki syndrome enables functional assessment of genetic variants of unknown clinical significance vol.12, pp.11, 2017, https://doi.org/10.1080/15592294.2017.1381807
  3. Update on 13 Syndromes Affecting Craniofacial and Dental Structures vol.8, pp.None, 2015, https://doi.org/10.3389/fphys.2017.01038
  4. Carotid artery occlusion in Kabuki syndrome: Case report and literature review vol.8, pp.1, 2017, https://doi.org/10.4103/sni.sni_427_16
  5. Genetic counseling in CHARGE syndrome: Diagnostic evaluation through follow up vol.175, pp.4, 2015, https://doi.org/10.1002/ajmg.c.31589
  6. 가부키 증후군(Kabuki syndrome) 환자의 치과적 관리의 치험례 vol.13, pp.2, 2017, https://doi.org/10.12655/kadh.2017.13.2.104
  7. Dissecting KMT2D missense mutations in Kabuki syndrome patients vol.27, pp.21, 2018, https://doi.org/10.1093/hmg/ddy241
  8. Atypical Autoimmune Hematologic Disorders in a Patient With Kabuki Syndrome vol.41, pp.2, 2019, https://doi.org/10.1097/mph.0000000000001182
  9. Epigenetic Priming in Immunodeficiencies vol.7, pp.None, 2019, https://doi.org/10.3389/fcell.2019.00125
  10. Kabuki syndrome: international consensus diagnostic criteria vol.56, pp.2, 2019, https://doi.org/10.1136/jmedgenet-2018-105625
  11. Inhibition of Notch signaling rescues cardiovascular development in Kabuki Syndrome vol.17, pp.9, 2015, https://doi.org/10.1371/journal.pbio.3000087
  12. Slipped Capital Femoral Epiphysis in an Adult Patient With Kabuki Syndrome vol.3, pp.10, 2015, https://doi.org/10.5435/jaaosglobal-d-19-00084
  13. Bonebridge implantation for mixed hearing loss in a patient with Kabuki syndrome vol.91, pp.3, 2015, https://doi.org/10.23750/abm.v91i3.8257
  14. Identification of KMT2D and KDM6A variants by targeted sequencing from patients with Kabuki syndrome and other congenital disorders vol.731, pp.None, 2020, https://doi.org/10.1016/j.gene.2020.144360
  15. Caregiver‐reported clinical characteristics and the burden associated with Kabuki syndrome vol.182, pp.7, 2015, https://doi.org/10.1002/ajmg.a.61584
  16. Expanding the phenotype of Wiedemann‐Steiner syndrome: Craniovertebral junction anomalies vol.182, pp.12, 2020, https://doi.org/10.1002/ajmg.a.61859
  17. Hypoglycemia and Dandy-Walker variant in a Kabuki syndrome patient: a case report vol.21, pp.1, 2015, https://doi.org/10.1186/s12881-020-01117-8
  18. KMT2C/D COMPASS complex-associated diseases [K CD COM-ADs]: an emerging class of congenital regulopathies vol.12, pp.None, 2015, https://doi.org/10.1186/s13148-019-0802-2
  19. Kabuki Syndrome: Identification of Two Novel Variants in KMT2D and KDM6A vol.12, pp.2, 2021, https://doi.org/10.1159/000513199
  20. A Novel Intronic KMT2D Variant as a Cause of Kabuki Syndrome: A Case Report vol.14, pp.None, 2015, https://doi.org/10.2147/tacg.s317723
  21. Could the MED13 mutations manifest as a Kabuki‐like syndrome? vol.185, pp.2, 2015, https://doi.org/10.1002/ajmg.a.61994
  22. Facial Dysmorphisms, Macrodontia, Focal Epilepsy, and Thinning of the Corpus Callosum: A Rare Mild Form of Kabuki Syndrome vol.10, pp.1, 2015, https://doi.org/10.1055/s-0040-1701645
  23. Kabuki Syndrome-Clinical Review with Molecular Aspects vol.12, pp.4, 2015, https://doi.org/10.3390/genes12040468